| $* Accutype(R) IL 28B (90251) | 6958 | Bs.105.841,28 |
| $* Acetylcholine Receptor Binding Antibody ( 206 ) | 7063 | Bs.35.990,52 |
| $* Acetylcholine Receptor Blocking Autoantibodies (34459) | 6667 | Bs.32.402,68 |
| $* Acetylcholine Receptor Modulating Autoantibodies (26474) | 6668 | Bs.73.662,84 |
| $* Achondroplasia Mutation Analysis (16061) | 7453 | Bs.89.359,64 |
| $* Adalimumab Anti-drug Antibody for IBD (36294) | 7854 | Bs.66.711,40 |
| $* Adalimumab Level for IBD (36298) | 8018 | Bs.66.711,40 |
| $* Adenosine, Deaminase, RBC (39148) | 7222 | Bs.41.596,52 |
| $* Admark phospho-Tau / total - Tau / A Beta 42 Analysis/Interp CSF(92433) | 7738 | Bs.154.052,88 |
| $* Adrenal Antibody Screen with Relex to Titer (4645) | 6813 | Bs.36.102,64 |
| $* Alkaline Phosphatase (ALP) ( 95502) | 7130 | Bs.3.475,72 |
| $* AML1/ ETO, T (8,21) Quantitative Real Time PCR (14995) | 6676 | Bs.65.926,56 |
| $* Amoxicillin (C6) IgE ( 38476) | 7054 | Bs.4.036,32 |
| $* Amylase Isoenzymes with Reflex to Macroamylase (36187) | 7197 | Bs.64.132,64 |
| $* Aspergillus DNA, Qualitative, Real-Time PCR (18873) | 7420 | Bs.97.544,40 |
| $* Aspergillus fumigatus IgG AB, Serum (92529) | 6826 | Bs.33.299,64 |
| $* Beta - Globin Compete ( 14974) | 7033 | Bs.145.419,64 |
| $* Bilirubin Fractionated ( 7286) | 6801 | Bs.3.587,84 |
| $* BK Virus DNA, Qualitative Real-Time PCR, Urine (16553) | 7193 | Bs.100.908,00 |
| $* BRAF Mutation Analysis (16767) | 7599 | Bs.98.889,84 |
| $* C-Kit Mutation Analysis, Cell Based (19961) | 7245 | Bs.208.318,96 |
| $* Campylobacter jejuni Antibodiy ELISA (10718) | 7519 | Bs.48.211,60 |
| $* Candida albicans Antibodies IgG, IgM,& IGA (30440) | 7567 | Bs.38.457,16 |
| $* CASPR2 Antibody Test (92413) | 7999 | Bs.134.768,24 |
| $* Chlamydia trachomatis Antibodies (IgG, IgA, IgM) (36581) | 7419 | Bs.31.393,60 |
| $* Cholinesterase RBC and Plasma (338) | 7167 | Bs.26.908,80 |
| $* Cholinesterase Serum (37965) | 7166 | Bs.11.772,60 |
| $* Chromosomal Microarray, Postnatal, ClariSure(R) Oligo-SNP (16478) | 7143 | Bs.499.830,96 |
| $* Connexin 26 (GJB2) DNA Sequencing Test ( 92435) | 6879 | Bs.186.904,04 |
| $* Coxiella burnetti DNA, Qualitative Real -Time PCR ( 16596) | 7225 | Bs.97.544,40 |
| $* Coxsackie A Antibodies Serum ( 37477) | 7584 | Bs.52.360,04 |
| $* Cysticercus Antibodiy IgG ELISA Serum (34173) | 7037 | Bs.41.484,40 |
| $* Cysticercus Antibodiy IgG ELISA Western Blot CSF (34869) | 7736 | Bs.56.956,96 |
| $* Cytomegalovirus IgG Avidity, ELISA (19583) | 6827 | Bs.30.945,12 |
| $* d-Xylose Absorption Test, Blood, Fasting (1198) | 7743 | Bs.26.684,56 |
| $* Delta -Aminolevulinic Acid , 24- Hour Urine (Delta ALA) (219) | 6944 | Bs.12.108,96 |
| $* Echovirus Antibody Panel ( Serotypes 4,7,9,11 and 30 ) (35139) | 7866 | Bs.56.060,00 |
| $* Enterovirus RNA, Qualitative RT -PCR (15082) | 6970 | Bs.68.729,56 |
| $* Eosinophil Cationic Protein (ECP) (37914) | 7965 | Bs.39.242,00 |
| $* Epstein - Barr virus DNA, qualitative real time - PCR (34179) | 6723 | Bs.68.729,56 |
| $* Epstein-Barr Virus Early Antigen D Antibody (IgG) 1(5447)) | 7538 | Bs.29.487,56 |
| $* Epstein-Barr Virus Nuclear Antigen (EBNA) Antibody (IgG) (8564) | 7539 | Bs.16.481,64 |
| $* Epstein-Barr Virus Viral Capsid Antigen (VCA) Antibody (IgG) (8474) | 7540 | Bs.16.481,64 |
| $* Epstein-Barr Virus Viral Capsid Antigen (VCA) Antibody (IgM) (8426) | 7541 | Bs.16.481,64 |
| $* Factor V HR2 Allele DNA Mutation Analysis (17902) Mutation A4070G (H1299R) | 7192 | Bs.73.438,60 |
| $* Filaria Ab IgG4 (34168) | 6809 | Bs.57.966,04 |
| $* FISH, B-Cell Chronic Lymphocytic Leukemia Panel (16864) | 7836 | Bs.151.025,64 |
| $* FISH, CML/ALL, bcr/abl, Translocation 9;22 ( 12070) (Philadelphia Chrom.) | 7105 | Bs.53.369,12 |
| $* FISH, HES/Leukemia, 4q12 Rearrangement (FIP1L1-PDGFRA) (16837) | 8064 | Bs.169.525,44 |
| $* FISH, MDS/Myeloid Panel, -5/5q-, -7/7q-, +8,20q- (19799) | 7729 | Bs.212.803,76 |
| $* FISH, N-myc Amplification, Neuroblastoma (14621) | 6796 | Bs.121.313,84 |
| $* FISH, Prader-Willi/Angelman Syndrome (14605) | 7004 | Bs.117.838,12 |
| $* FISH, Williams Syndrome (14609) | 7803 | Bs.117.838,12 |
| $* FTA-ABS (4112) | 7761 | Bs.5.830,24 |
| $* GAD65 Neurological Syndrome Antibody Testy (92414) | 7677 | Bs.114.474,52 |
| $* Ganglioside Asialo - GM1 Antibody (IgM) ( 38836) | 7106 | Bs.30.945,12 |
| $* Ganglioside Asialo-GM-1 Antibody (IgG), EIA ( 39462) | 7107 | Bs.34.196,60 |
| $* Ganglioside GQ1B Antibody (IgG), EIA (34144) | 7565 | Bs.22.424,00 |
| $* Giardia lamblia IgG, igA, IgM antibody Paneil IFA (34187) | 7721 | Bs.80.838,52 |
| $* Haemophilus influenzae Type B Antibody (IgG)(35135) | 7048 | Bs.21.302,80 |
| $* Hemoglobinopathy evaluation (35489) | 7035 | Bs.14.687,72 |
| $* Hepatitis E Virus (HEV) Antibodies (IgG, IgM) (15085) | 7774 | Bs.41.035,92 |
| $* Hereditary Hemochromatosis DNA Mutation Analysis (Gen HFE, C282, H63D) (35079) | 6624 | Bs.42.045,00 |
| $* Herpesvirus 6 Antibodies (IgG, IgM) (34282) | 7960 | Bs.37.784,44 |
| $* Herpesvirus 7 Antibody Panel (IgG, IgM), IFA (10937) | 7961 | Bs.107.298,84 |
| $* Histoplasma capsulatum DNA, PCR ( 90249 ) | 6721 | Bs.135.889,44 |
| $* HLA - A High Resolution (17397) | 7131 | Bs.32.066,32 |
| $* HLA - C Low Resolution Typing (15463) | 6622 | Bs.48.211,60 |
| $* HLA -B High Resolution (17396) | 7132 | Bs.63.235,68 |
| $* HLA -DQB1 Low Resolution(10953) | 7154 | Bs.37.335,96 |
| $* HLA A29 Birdshot Retinochoroidopathy (16773) | 7852 | Bs.37.335,96 |
| $* HLA B Low Resolution (10950) | 7753 | Bs.19.172,52 |
| $* HLA B51 Behcet's Disease Association Test (16775 ) | 6857 | Bs.60.544,80 |
| $* HLA- DQ High Resolution ( 17394 ) | 7134 | Bs.69.514,40 |
| $* HLA- DQA1 Low Resolution (19525 ) | 7153 | Bs.37.335,96 |
| $* HLA- DRB1 High Resolution ( 17393 ) | 7133 | Bs.69.514,40 |
| $* Hu Antibody screen with reflex to titter and Western Blot CSF(37710) | 7643 | Bs.101.468,60 |
| $* Hu Antibody screen with reflex to titter and Western blot (37053) | 7032 | Bs.54.490,32 |
| $* Hu, Yo, and Ri Antibodies with Reflex to Titers and Western Blot (90138) | 7417 | Bs.141.943,92 |
| $* Huntington Disease Mutation Analysis (10247) | 6637 | Bs.114.586,64 |
| $* Hyaluronic Acid, Serum (92550) | 7564 | Bs.104.271,60 |
| $* IgG Synthesis Rate, CNS Index (7558 ) | 7117 | Bs.57.405,44 |
| $* Infliximab Level and Anti-drug Antibody for IBD (36311 ) | 7979 | Bs.133.422,80 |
| $* Infliximab Level for IBD (36303 ) | 8001 | Bs.66.711,40 |
| $* JC Polyoma Virus DNA, Quantitative, Real-Time PCR, CSF (16442) | 6803 | Bs.114.362,40 |
| $* KRAS Mutation Analysis (16510) | 7065 | Bs.129.274,36 |
| $* Lactate Dehydrogenase (LD) Isoenzyme Panel (4411) | 8066 | Bs.20.630,08 |
| $* Leptin (90367) | 7149 | Bs.22.424,00 |
| $* LGI1 Antibody Test (92416) | 7618 | Bs.137.459,12 |
| $* Lipoprotein Electrophoresis (35436) | 7956 | Bs.20.181,60 |
| $* Liver Cytosolic Antigen Type 1 (LC-1) Antibody, IgG (13554) | 7208 | Bs.48.211,60 |
| $* Lung Cancer Mutation panel (EGFR, KRAS, ALK) (91216) | 7179 | Bs.320.887,44 |
| $* Magnesium, RBC (623 ) | 6706 | Bs.13.454,40 |
| $* Measles antibodies ( IgM) (Sarampion) (34256 ) | 6966 | Bs.18.611,92 |
| $* Measles IgG (Sarampion) (964 ) | 6967 | Bs.16.930,12 |
| $* MEN1 Sequencing and Deletion/Duplication (93942) | 7652 | Bs.88.126,32 |
| $* Methylenetetrahydrofolate reductase, DNA Mutacion Analysis (MTHFR) 17911 | 7644 | Bs.90.032,36 |
| $* Microsatellite Instability (MSI) (14989) | 7600 | Bs.163.695,20 |
| $* Multiple Sclerosis Panel 2 (7085) | 6856 | Bs.123.107,76 |
| $* Mycobacterium avium-intracellulare DNA, Qualitative, Real-Time PCR (16064) | 7581 | Bs.132.862,20 |
| $* Mycobacterium Tuberculosis Complex PCR Respiiratory (30298) | 6692 | Bs.62.899,32 |
| $* Mycobacterium tuberculosis Complex, PCR, Non-Respiratory (30277) | 7865 | Bs.57.181,20 |
| $* Myelin - Associated Glycoprotein (MAG) Antibody IgM (37438) | 6974 | Bs.37.672,32 |
| $* Myelin Oligodendrocyte Glycoprotein(MOG)Antibody with Reflex to Titer,CSF (36954) | 8020 | Bs.257.315,40 |
| $* NeoCerebellar Degeneration Paraneoplastic Profile with Recombx (91623) | 7175 | Bs.563.403,00 |
| $* NF1 Sequencing and Deletion / Duplication (93941) (Neurofibromatosis) | 7517 | Bs.88.126,32 |
| $* NMDA Receptor (NR1-subunit) Autoantibody Test ( 92394 ) | 7518 | Bs.90.032,36 |
| $* NRAS Mutation Analysis (16818) | 7064 | Bs.129.274,36 |
| $* Oligoclonal Bands (674) | 6811 | Bs.32.739,04 |
| $* Ovarian Antibody Screen with Reflex to Titer, IFA (10328) | 6677 | Bs.31.505,72 |
| $* Parvovirus B19 DNA Qualitative Real Time (PCR) (34296) | 7859 | Bs.43.726,80 |
| $* Parvovirus B19 DNA Quantitative Real Time (PCR) (19724) | 6960 | Bs.103.823,12 |
| $* PCNA Antibody, IFA ( Proliferating Cell Nuclear) (16010) | 7088 | Bs.16.818,00 |
| $* Penicilloyl G (C1) IgE (702) | 7055 | Bs.4.036,32 |
| $* Penicilloyl V (C2) IgE (703) | 7057 | Bs.4.036,32 |
| $* Phosphatidylcholine Antibodies (IgG, IgA, IgM) panel (13082) | 7125 | Bs.19.060,40 |
| $* Phosphatidylethanolamine Antibodies (IgG, IgA, IgM) (12023) | 7126 | Bs.7.287,80 |
| $* Phosphatidylglycerol Antibodies, IgG, IgM and IgA (10521) | 7860 | Bs.7.287,80 |
| $* Phosphatidylinositol Antibodies (IgG, IgM, IgA) (10480) | 7861 | Bs.7.287,80 |
| $* Phospholipase A2 Receptor (PLA2R) Antibody, ELISA (39245) | 7772 | Bs.75.793,12 |
| $* plasma Phagocytophilum And Ehrlichia Chaffeensis AB panel (10611) | 7257 | Bs.106.514,00 |
| $* Porphobliinogen Quantitative , Random Urine (6329) | 6771 | Bs.18.724,04 |
| $* Porphyrins Fractionated Quantitative Urine Random (36592) | 6772 | Bs.24.666,40 |
| $* Prader-Willi/Angelman Syndrome, DNA Methylation Analysis (11369) | 7930 | Bs.129.274,36 |
| $* Protein Electrophoresis (PEP) Evaluation CSF (749) | 7413 | Bs.41.596,52 |
| $* Purkinje Cell Cytoplasmic Antibody Type Tr (DNER), CBA IFA (93894) | 7718 | Bs.106.738,24 |
| $* Pyruvate CSF ( 38363) | 7142 | Bs.39.242,00 |
| $* RAS Mutation Analysis, Thyroid Cancer (90479) | 7433 | Bs.248.570,04 |
| $* Recombx® Amphiphysin Autoantibody Test (4674) | 8013 | Bs.102.814,04 |
| $* Recombx® CAR (Anti-Recoverin) Autoantibody Test (4684) | 6694 | Bs.116.044,20 |
| $* Recombx® CV2 Autoantibody Test (4681) | 7050 | Bs.114.362,40 |
| $* Recombx® Zic4 Autoantibody Test (4689) | 7788 | Bs.108.756,40 |
| $* Rett Syndrome Sequence Analysis (15088) | 6989 | Bs.231.191,44 |
| $* Rickettsia (RMSF) Antibodies IgG, IgM with Reflex toTiters (6419 ) | 6890 | Bs.90.256,60 |
| $* Rickettsia (Typhus Fever) Antibodies (IgG, IgM) with Reflex to Titers (37503) | 6889 | Bs.91.938,40 |
| $* Rickettsia Species DNA, Real Time PCR (70191) | 6722 | Bs.94.180,80 |
| $* Rubella Antibodies (IgG, IgM) Diagnostic (37673) | 7313 | Bs.68.056,84 |
| $* Rubella Antibody IgM (4422) | 7302 | Bs.51.350,96 |
| $* Salmonella total Antibody, EIA (10582) | 7458 | Bs.19.621,00 |
| $* SCE / Infliximab Level for Rheumatic Diseases (36310 ) | 7767 | Bs.66.711,40 |
| $* SCE / Iron, Total and Total Iron Binding Capacity (7573) | 7575 | Bs.9.866,56 |
| $* SCE / Myasthenia Gravis Evaluation (266, 206) | 6655 | Bs.36.439,00 |
| $* SCE / Myelin Antibody IgG IFA (4639) | 6649 | Bs.11.212,00 |
| $* SCE / Soluble Liver Antigen Autoantibodies (SLA) Autoabs (Antic. anti Antígeno Soluble Hígado) (38928) | 6874 | Bs.23.769,44 |
| $* SCE/ Glutamic Acid Decarboxylase-65 Antibody ( GAD ) (34878) | 7606 | Bs.34.757,20 |
| $* SCE/ Infliximab Anti-drug Antibody for Rheumatic Diseases (36302 ) | 7506 | Bs.66.711,40 |
| $* Schistosoma Antibody (IgG), FMI (34306) | 6808 | Bs.44.511,64 |
| $* Spinal Muscular Atrophy Diagnostic Test (SMA) (16869) | 6570 | Bs.126.695,60 |
| $* Sports 1 Expanded (38555) | 7256 | Bs.17.939,20 |
| $* Stratify JCV Antibody (with Index) with Reflex to Inhibition Assay (91665) | 7775 | Bs.403.407,76 |
| $* Striated Muscle Antibody with Reflex to Titer ( 266) | 7062 | Bs.13.454,40 |
| $* T 3 Uptake (861) | 8009 | Bs.2.915,12 |
| $* Thiopurine Metabolites (91745) (6-TG / G-MMP) | 7069 | Bs.28.590,60 |
| $* Titin Autoantibody Test (92792 ) | 7303 | Bs.121.874,44 |
| $* TMAO (Trimethylamine N-Oxide) (94154) | 8053 | Bs.14.575,60 |
| $* Toxocara Antiboy (IgG), Serum, (34304) | 6714 | Bs.22.087,64 |
| $* Toxoplasma Gondii IgA Antibody (ELISA) (17086) | 6998 | Bs.20.966,44 |
| $* Tryptase (34484) | 6693 | Bs.15.696,80 |
| $* Tysabri Antibodies Test (19215) | 6636 | Bs.161.452,80 |
| $* Varicella Zoster Virus DNA, Qualitative, Real - time PCR ( 34052) | 7525 | Bs.73.438,60 |
| $* Voltage-Gated Calcium Channel (VGCC) Type P/Q Antibody (34057) | 7653 | Bs.98.105,00 |
| $* Yersinia Enterecolitica Antibodies (IgG, IgA) (16768) | 7459 | Bs.55.611,52 |
| $* Yo Antibody Screen with Reflex to Titer and Western Blot ( 90119) | 7114 | Bs.78.484,00 |
| $* Yo Antibody Screen with Reflex to Titer and Western Blot CSF ( 90117) | 7642 | Bs.136.337,92 |
| $# BAFS / Bile Acids, Fractionated and Total, Serum | 7452 | Bs.64.356,88 |
| $# FSOMA/ Somatostatin (Somatotropin Release-Inhibiting Factor, SRIF) | 7554 | Bs.54.714,56 |
| $# IGD/ Immunoglobulin D (IgD), Serum | 7118 | Bs.7.848,40 |
| $# PMLR / PML/RARA Quantitative, PCR Varies | 7061 | Bs.170.870,88 |
| $# TIS / Titanium, Serum | 7713 | Bs.84.090,00 |
| $# 17OHP /17-Hydroxypregnenolone, Serum | 7526 | Bs.28.030,00 |
| $# 1A2Q / Cytochrome P450 1A2 Genotype, Varies | 7811 | Bs.147.213,56 |
| $# 1DIS / Human Leukocyte Antigens (HLA) A-B-C Disease Association Typing Low Resolution, Blood | 6716 | Bs.51.014,60 |
| $# 21OH / Hydroxylase Antibodies, Serum | 7205 | Bs.24.217,92 |
| $# 23BPR / 2,3-Dinor-11Beta-Prostaglandin F2 Alpha, Random, Urine | 7082 | Bs.12.557,44 |
| $# 2B6Q / Cytochrome P450 2B6 Genotype, Varies | 7812 | Bs.196.210,00 |
| $# 2C19R / Cytochrome P450 2C19 Genotype, Varies | 7813 | Bs.196.210,00 |
| $# 2C9QT/ Cytochrome P450 2C9 Genotype, Varies | 7814 | Bs.196.210,00 |
| $# 2D6Q/ Cytochrome P450 2D6 Cpmprehensive Cascade, Varies | 7815 | Bs.1.391.969,80 |
| $# 2DIS/ Human Leukocyte Antigens (HLA)-DR-DQ Disease Association Typing Low Resolution, Blood | 6555 | Bs.33.636,00 |
| $# 3A4Q / Cytochrome P450 3A4 Genotype, Varies | 7816 | Bs.179.952,60 |
| $# 3A5Q / Cytochrome P450 3A5 Genotype, Varies | 7817 | Bs.179.952,60 |
| $# 8INHE / Factor VIII Inhibitor Evaluation, Plasma | 8056 | Bs.140.934,84 |
| $# 9INHE / Factor IX Inhibitor Evaluation, Plasma | 8065 | Bs.155.846,80 |
| $# A1APP /Alpha-1-Antitrypsin Phenotype | 7007 | Bs.6.727,20 |
| $# AACSF / Amino Acids, Quantitative, Spinal Fluid | 7806 | Bs.53.817,60 |
| $# AAPD / Amino acids, quantitative, random, urine | 6659 | Bs.22.424,00 |
| $# AAQP / Amino acids, quantitative, plasma | 6660 | Bs.22.424,00 |
| $# AAT / Alpha-1-Antitrypsin, Serum | 7072 | Bs.3.587,84 |
| $# AAUCD /Amino Acids, Urea Cycle Disorders Panel | 7425 | Bs.21.527,04 |
| $# AB2GP / Beta-2 Glycoprotein 1 Antibodies, IgA, Serum | 7940 | Bs.5.942,36 |
| $# ACE/ Angiotensin Converting Enzyme, Serum | 6619 | Bs.3.924,20 |
| $# ACLIP/ Phospholipid (Cardiolipin) Antibodies, IgA, Serum | 6602 | Bs.6.727,20 |
| $# ACRN / Acylcarnitines, Quantitative, Plasma | 6582 | Bs.7.960,52 |
| $# ACTH / Adrenocorticotropic Hormone (ACTH), Plasma | 6825 | Bs.6.951,44 |
| $# ADM13 / ADAMTS13 Activity and Inhibitor Profile | 7422 | Bs.64.805,36 |
| $# ADNAS / Anti-DNase B Titer, Serum | 7392 | Bs.48.996,44 |
| $# AH50 / Alternative Complement Pathway, Functional, Serum | 7958 | Bs.16.257,40 |
| $# AHDV / Hepatitis D Virus total Antibodies, Serum (Delta) | 7899 | Bs.28.254,24 |
| $# AIHL / Aminoglycoside-Induced Hearing Loss, Targeted Variant Testing, Droplet Digital PCR, Varies | 7809 | Bs.192.285,80 |
| $# AL / Aluminum, serum | 6988 | Bs.6.278,72 |
| $# ALBR / Albumin, Random, Urine | 7449 | Bs.3.924,20 |
| $# ALDS / Aldosterone, Serum | 6697 | Bs.7.287,80 |
| $# ALDU / Aldosterone, 24 Hour, Urine | 7122 | Bs.16.818,00 |
| $# ALGAL /Galactose-Alpha-1,3-Galactose (Alpha-Gal), IgE, Serum | 7757 | Bs.22.984,60 |
| $# ALKI / Alkaline Phosphatase, Total and Isoenzymes, Serum | 7883 | Bs.9.193,84 |
| $# ALS / Aldolase, Serum | 6589 | Bs.2.466,64 |
| $# AMA / Mitochondrial Antibodies (M2), Serum | 7691 | Bs.3.363,60 |
| $# AMIO / Amiodarone | 6775 | Bs.5.830,24 |
| $# AMLF/ Acute Myeloid Leukemia (AML), FISH | 6587 | Bs.150.913,52 |
| $# AMP / Ampicillin, IgE, Serum | 7873 | Bs.5.381,76 |
| $# AMPIP / Amyloid Protein Identification, Paraffin, LC-MS/MS (Reflex) | 7582 | Bs.328.063,12 |
| $# ANAP / Anaplasma phagocytophilum (Human Granulocytic Ehrlichiosis) Antibody, Serum | 8007 | Bs.14.575,60 |
| $# APCRV / Activated Protein C Resistance V (APCRV), Plasma | 7516 | Bs.15.472,56 |
| $# APLA1 / Apolipoprotein A1, Plasma | 7090 | Bs.6.502,96 |
| $# APLB / Apolipoprotein B, Plasma | 7091 | Bs.8.969,60 |
| $# APOEG / Apolipoprotein E Genotyping, Blood | 7399 | Bs.60.881,16 |
| $# ARBI Acetylcholine Receptor (Muscle AChR) Binding Antibody, Serum | 7365 | Bs.14.015,00 |
| $# ASB / Arsenic, Blood | 6628 | Bs.5.606,00 |
| $# ASP/ Aspergillus fumigatus, IgE | 7935 | Bs.5.381,76 |
| $# ASPAG/ Aspergillus (Galactomannan) Antigen, Serum | 7067 | Bs.17.042,24 |
| $# ASPBA / Aspergillus Antigen, Bronchoalveolar Lavage | 7726 | Bs.17.042,24 |
| $# ATTI / Antithrombin Antigen, Plasma | 7213 | Bs.9.530,20 |
| $# B6PRO / Vitamin B6 Profile (PLP and PA), Plasma | 7112 | Bs.40.363,20 |
| $# BABPB / Babesia species, Molecular Detection, PCR, Blood | 7997 | Bs.31.954,20 |
| $# BADX / BCR/ABL1, Qualitative, Diagnostic Assay, Varies | 6793 | Bs.148.895,36 |
| $# BAKDM / BCR/ABL1, Tyrosine Kinase Inhibitor Resistance, Kinase Domain Mutation Sc. Sanger Sequencing, Varies | 6968 | Bs.285.121,16 |
| $# BALPF / B-Cell Acute Lymphoblastic Leukemia/Lymphoma (ALL), Pediatric, FISH, Varies | 7009 | Bs.704.898,44 |
| $# BAP / Bone Alkaline Phosphatase, Serum | 7481 | Bs.9.305,96 |
| $# BART / Bartonella Antibody Panel, IgG and IgM, Serum (henselae, quintana) | 6886 | Bs.12.333,20 |
| $# BARTB / Bartonella, Molecular Detection, PCR, Blood | 8041 | Bs.33.411,76 |
| $# BETA2 / Beta-2 Transferrin, Detection of Spinal Fluid in Other Body Fluid | 7070 | Bs.23.320,96 |
| $# BHCG / Beta-Human Chorionic Gonadotropin, Quantitative, Serum | 7520 | Bs.60.769,04 |
| $# BHYD / Beta-Hydroxybutyrate, Serum | 7010 | Bs.5.830,24 |
| $# BILEA / Bile Acids, Total, Serum | 7872 | Bs.30.496,64 |
| $# BIOTS / Biotinidase, Serum | 7431 | Bs.36.999,60 |
| $# BLPMF / B-Cell Lymphoma Specified FISH, Varies | 7274 | Bs.159.210,40 |
| $# BLYM / B-Cell Lymphoma, FISH, Tissue | 7058 | Bs.197.891,80 |
| $# BNP/ B-Type Natriuretic Peptide (BNP), Plasma B-Type Natriuretic Peptide (BNP), Plasma | 6654 | Bs.27.469,40 |
| $# BNZU / Benzodiazepines Confirmation, Random, Urine (cualitativo) | 7588 | Bs.72.878,00 |
| $# BORDG / Bordetella pertussis Antibody, IgG, Serum | 7959 | Bs.44.960,12 |
| $# BPAP / Bullous Pemphigoid, BP180 and BP230, IgG Antibodies, Serum | 7441 | Bs.35.317,80 |
| $# BRAFB / Cell-Free DNA BRAF V600 Test | 7464 | Bs.152.258,96 |
| $# BRCMG / Brucella Antibody Screen, IgG and IgM, Serum | 6945 | Bs.8.633,24 |
| $# BTKSG / Bruton Tyrosine Kinase, BTK Full Gene Analysis, Varies | 7119 | Bs.347.684,12 |
| $# BWRS / Beckwith-Wiedemann Syndrome (BWS)/Russell-Silver Syndrome (RSS) Molecular Analysis | 7227 | Bs.136.562,16 |
| $# C1ES / C1 Esterase (C1ES) Inhibitor Antigen, Serum | 6626 | Bs.6.166,60 |
| $# C1Q /Complement C1q, Serum | 6846 | Bs.11.212,00 |
| $# C1QFX /Complement , Funcitional , Serum | 7254 | Bs.15.696,80 |
| $# C2FXN /C2 Complement, Functional, Serum | 7095 | Bs.12.669,56 |
| $# C3 / Complement C3, Serum | 7096 | Bs.3.587,84 |
| $# C4 / Complement C4, Serum | 7097 | Bs.3.587,84 |
| $# C5AG / C5 Complement, Antigen, Serum | 7098 | Bs.14.575,60 |
| $# C5FX / C5 Complement, Functional, Serum | 7720 | Bs.17.939,20 |
| $# C6FX / C6 Complement, Functional, Serum | 7099 | Bs.17.042,24 |
| $# C7FX / C7 Complement, Functional, Serum | 7100 | Bs.17.939,20 |
| $# C8FX / C8 Complement, Functional, Serum | 7101 | Bs.17.939,20 |
| $# C9FX / C9 Complement, Functional, Serum | 7102 | Bs.17.939,20 |
| $# CAI / Calcium, Ionized, Serum | 8023 | Bs.4.484,80 |
| $# CALPR / Calprotectin, Feces | 7550 | Bs.30.048,16 |
| $# CALR / CALR Mutation Analysis, Myeloproliferative Neoplasm (MPN), Varies | 7992 | Bs.145.756,00 |
| $# CARBR / Carbamazepine Hypersensitivity Pharmacogenomics, Varies | 7808 | Bs.163.134,60 |
| $# CARN/ Carnitine, Plasma | 6583 | Bs.5.269,64 |
| $# CARTA / Carbamazepine, Total, Serum ( Tegretol ) | 7157 | Bs.9.866,56 |
| $# CATN/ Calcitonin, Serum | 6702 | Bs.8.969,60 |
| $# CATU Catecholamine Fractionation, Free, 24 Hour, Urine | 7363 | Bs.9.530,20 |
| $# CDB / Cadmium, Blood | 7030 | Bs.9.530,20 |
| $# CDHZ / Hereditary Diffuse Gastric Cancer Syndrome, CDH1, Full Gene Analysis, Varies | 7833 | Bs.317.972,32 |
| $# CERS / Ceruloplasmin, Serum | 6717 | Bs.2.803,00 |
| $# CFTRZ / CFTR Gene, Full Gene Analysis, Varies | 7574 | Bs.156.968,00 |
| $# CGAK/ Chromogranin A, Serum | 6553 | Bs.45.632,84 |
| $# CHF8/ Chromogenic Factor VIII Activity Assay, Plasma | 8055 | Bs.99.226,20 |
| $# CHF8P / Chromogenic Factor VIII Inhibitor Bethesda Profile, Plasma | 8057 | Bs.142.168,16 |
| $# CHLAP / Chlamydia IgM and IgG Panel, Immunofluorescence, Serum (pheumoniae, psitacci ) IgG, IgM | 7015 | Bs.12.669,56 |
| $# CHLGP / Cholestasis Gene Panel, Varies | 7881 | Bs.600.738,96 |
| $# CIFS/ Cutaneous Immunofluorescence Antibodies (IgG), Serum ( Epidermiosis ampollar) | 6880 | Bs.188.922,20 |
| $# CLFAT / Cryptococcus Antigen Titer, LFA, Spinal Fluid (Neoformans) | 6979 | Bs.9.305,96 |
| $# CLLDF / Chronic Lymphocytic Leukemia (CLL), Diagnostic FISH, Varies | 6614 | Bs.237.806,52 |
| $# CMACB / Chromosomal Microarray, Congenital, Blood | 7043 | Bs.288.933,24 |
| $# CMVQN / Cytomegalovirus DNA Detection and Quantification by Real -Time PCR, Plasma | 6640 | Bs.20.181,60 |
| $# COHBB / Carbon Monoxide, Blood ( Carboxyhemoglobin) | 7171 | Bs.29.375,44 |
| $# COMCP / Hereditary Common Cancer Panel, Varies, | 7975 | Bs.652.986,88 |
| $# COMTQ / Catechol-O-Methyltransferase (COMT) Genotype, Varies | 7810 | Bs.188.025,24 |
| $# CORTU/ Cortisol, Free, 24 hour Urine | 7123 | Bs.5.830,24 |
| $# COS / Cobalt, Serum | 7249 | Bs.16.481,64 |
| $# COU / Cobalt, 24 Hour, Urine | 7473 | Bs.16.593,76 |
| $# COVSQ / (SARS-CoV-2), Spike Ab. Semi-Quantitative,Srum | 7664 | Bs.28.030,00 |
| $# CPAVP / Copeptin ProAVP, Plasma (arginine vasopressin) | 7512 | Bs.94.741,40 |
| $# CRDPU / Creatine Disorders Panel, Random, Urine | 8063 | Bs.77.923,40 |
| $# CRS/ Chromium, Serum | 7251 | Bs.7.287,80 |
| $# CRU/ Chromium, 24 Hour, Urine | 7475 | Bs.10.090,80 |
| $# CRYPS / Cryptosporidium Antigen, Feces | 7875 | Bs.12.108,96 |
| $# CSMHU / Controlled Substance Monitoring Hybrid Drug Profile, 20 Drug Classes, HPLC Random Urine | 7924 | Bs.96.983,80 |
| $# CSTCE / Cystatin C with Estimated Glomerular Filtration Rate (eGFR), Serum | 7271 | Bs.11.212,00 |
| $# CTX / Beta-CrossLaps (Beta-CTx), Serum | 6947 | Bs.5.942,36 |
| $# CURCU / Copper/Creatinine Ratio, Random, Urine (cobre) | 6792 | Bs.10.651,40 |
| $# CUS1 / Copper, Serum ( cobre) | 6641 | Bs.4.484,80 |
| $# CUU /Copper, 24 Hour, Urine | 6812 | Bs.10.651,40 |
| $# CYCPK / Cyclosporine, Peak Blood | 7759 | Bs.5.830,24 |
| $# CYPZ/ 21-Hydroxylase Gene (CYP21A2), Full Gene Analysis | 6566 | Bs.349.365,92 |
| $# CYSPR / Cyclosporine, Blood | 7315 | Bs.5.830,24 |
| $# CYSQN Cystinuria Profile, Quantitative, 24 Hour, Urine | 7218 | Bs.30.272,40 |
| $# CYSR / Cystinuria Profile, Quantitative, Random, Urine | 6687 | Bs.22.424,00 |
| $# DBMD / Duchenne/Becker Muscular Dystrophy DMD Gene, Large Deletion and Duplication Analysis | 7318 | Bs.191.837,32 |
| $# DCORT / 11- Deoxicortisol, serum ( compuesto S ) | 6671 | Bs.10.427,16 |
| $# DCP/ Des-Gamma-Carboxy Prothrombin (DCP), Serum | 7430 | Bs.76.577,96 |
| $# DDITT / D-Dimer, plasmas | 7418 | Bs.13.454,40 |
| $# DHES1/ Dehydroepiandrosterone Sulfate, Serum | 7671 | Bs.5.942,36 |
| $# DHTS / Dihydrotestosterone, Serum | 7535 | Bs.12.108,96 |
| $# DHVD/ 1,25-Dihydroxyvitamin D, Serum | 6842 | Bs.8.969,60 |
| $# DIG / Digoxin serum | 7357 | Bs.13.790,76 |
| $# DIPGS / Diphtheria Toxoid IgG Antibody, Serum | 7905 | Bs.9.754,44 |
| $# DNSAG / Dengue Virus NS1 Antigen, Serum | 8052 | Bs.38.120,80 |
| $# DPYDG / Dihydropyrimidine Dehydrogenase, DPYD Full Gene Sequencing, Varies | 7819 | Bs.211.346,20 |
| $# DPYDQ / Dihydropyrimidine Dehydrogenase Genotype, Varies | 7818 | Bs.205.179,60 |
| $# DSGAB / Desmoglein 1 (DSG1) and Desmoglein 3 (DSG3), IgG Antibodies, Serum | 7754 | Bs.23.881,56 |
| $# E1 / Estrone, Serum | 7637 | Bs.8.184,76 |
| $# EBVQN / Epstein-Barr Virus DNA Detection and Quantification, Plasma (Carga viral) | 7428 | Bs.24.105,80 |
| $# ECHNG / Echinococcus Antibody, IgG, Serum (Hidatidiosis) | 6838 | Bs.22.984,60 |
| $# EDSGP / Ehlers-Danlos Syndrome Panel (12 Genes), Next-Gen. Seq. and Deleti./Duplication Analysis, Varie | 7739 | Bs.514.855,04 |
| $# EGFRS / EGFR / Targeted Mutation Analysis, 51 Mutation Panel, Tumor | 7462 | Bs.448.480,00 |
| $# EHBAP / Ehrlichia/Babesia / Anaplasma Antibody Panel, Immunofluorescence, Serum (IgG) | 8008 | Bs.126.359,24 |
| $# EHOLG / Entamoeba histolytica Antibody, Serum (Amebiasis) | 6839 | Bs.9.530,20 |
| $# EHRCP / Ehrlichia, Anaplasma Antibody Panel, Serum) (IgG) | 6868 | Bs.17.939,20 |
| $# ELASF/ Pancreatic Elastase , Feces (fecal) | 7435 | Bs.29.151,20 |
| $# ENC2 / Encephalopathy, Autoimmune Evaluation, Spinal Fluid | 6632 | Bs.2.048.768,76 |
| $# ENS2 / Encephalopathy, Autoimmune/Paraneoplastic Evaluation, Serum | 6631 | Bs.2.048.768,76 |
| $# ENTP/ Enterovirus, Molecular Detection, PCR Plasma | 8035 | Bs.18.611,92 |
| $# EOSDF/ Chronic Eosinophilia, Diagn. FISH, Varies (CHIC2 deletion with FIP1L1/PDGFRA | 7283 | Bs.267.742,56 |
| $# EPCRB / Ehrlichia/Anaplasma, Molecular Detection, PCR, Blood | 7012 | Bs.23.320,96 |
| $# ETHSX / Ethosuximide, Serum (Zarontin) | 6834 | Bs.10.427,16 |
| $# EVROL / Everolimus, Blood | 7445 | Bs.14.239,24 |
| $# EZNT8 / Zinc Transporter 8 (ZnT8) Antibody, Serum | 7787 | Bs.177.822,32 |
| $# F_10/ Coagulation Factor X Activity Assay, Plasma | 6577 | Bs.10.090,80 |
| $# F_2 / Coagulation Factor II Activity Assay, Plasma | 6610 | Bs.11.772,60 |
| $# F_7/ Coagulation Factor VII Activity Assay, Plasma | 7374 | Bs.11.436,24 |
| $# F100B / S-100B Protein, Serum | 7996 | Bs.50.229,76 |
| $# F11DX / 11-Desoxycortisol (Compuesto S) | 7878 | Bs.56.956,96 |
| $# F2ISO/ F2- Iisoprostanes, Random, Urine | 7929 | Bs.117.950,24 |
| $# F5DNA / Factor V Leiden (R506Q) Mutation, Blood | 6573 | Bs.10.427,16 |
| $# F5NUL / 5'Nucleotidase | 7706 | Bs.26.684,56 |
| $# F68KD / 68kD (hsp-70) antibodies by Line Blot (Sordera Autoinmune) (otoblot) | 7013 | Bs.33.972,36 |
| $# FABP / Amyloid Beta-Protein, Plasma | 7737 | Bs.76.241,60 |
| $# FABRZ / Fabry Disease, Full Gene Analysis | 7443 | Bs.289.605,96 |
| $# FACEC / Angiotensin Converting Enzyme, CSF | 7751 | Bs.18.275,56 |
| $# FACES / Acetoacetate, Serum | 7011 | Bs.37.896,56 |
| $# FACT / F-Actin Ab, IgG, Serum | 7990 | Bs.58.302,40 |
| $# FACTV / Coagulation Factor V Activity Assay, Plasma | 7414 | Bs.10.090,80 |
| $# FADPF / Adenosine Deaminase, Pleural Fluida (ADA) | 7645 | Bs.32.066,32 |
| $# FAMDA / Anti-MDA-5 Ab (CADM-140) | 7641 | Bs.29.375,44 |
| $# FANDR / Androstenedione | 7969 | Bs.8.745,36 |
| $# FANGI / Angiotensin I, Plasma | 7243 | Bs.48.211,60 |
| $# FAPCP / Fatty Acid Profile, Comprehensive (C8-C26), Serum ( Acidos grasos Iintegral) | 7717 | Bs.33.636,00 |
| $# FAPEP / Fatty Acid Profile, Essential, Serum | 7614 | Bs.22.424,00 |
| $# FASAB / Aspergillus Antibodies, Quantitative, DID (fumigatus, niger, flavus) | 6971 | Bs.29.375,44 |
| $# FASPG / Aspergillus IgG Precipitins Panel | 8034 | Bs.36.102,64 |
| $# FAT1G / Anti-TIF-1gamma Antibody | 7804 | Bs.29.375,44 |
| $# FAU3R / Anti-U3 RNP Antibodies (Fibrillarin) | 7876 | Bs.21.078,56 |
| $# FBARS / Barium, Serum | 7247 | Bs.26.460,32 |
| $# FBIOT / Vitamin B7, H (Biotin) | 7705 | Bs.29.375,44 |
| $# FBIS / Bismuth, Serum | 7248 | Bs.114.586,64 |
| $# FBIUR / Bicarbonate, Urine | 7903 | Bs.22.424,00 |
| $# FC4AL / C4 Level by RIA | 7708 | Bs.39.914,72 |
| $# FCCEV / Notch3 DNA Sequencing Test | 6999 | Bs.381.880,72 |
| $# FCERT / Certolizumab pegol and Anti-Certolizumab Antibodies, Serum | 7423 | Bs.76.241,60 |
| $# FCYNB / Cyanide, Blood test (cianuro) | 6629 | Bs.24.554,28 |
| $# FDA1S / Drugs of Abuse (10 panel) and Alcohol Screen, Serum | 7571 | Bs.189.482,80 |
| $# FEHAG / Entamoeba histolytica Antigen, EIA (Amebiasis) | 7874 | Bs.35.317,80 |
| $# FFRED / Friedreich Ataxia Repeat Expansion Analysis - Unknown Mutation | 6955 | Bs.146.877,20 |
| $# FFRWB / Friedreich Ataxia, Frataxin, Quantitative, Whole Blood | 6853 | Bs.150.240,80 |
| $# FFTIB / Tin, Blood (Estaño) | 7252 | Bs.22.199,76 |
| $# FFTIO / Thiocyanate, Serum | 7954 | Bs.27.245,16 |
| $# FFTPO / Thrombopoietin (TPO) | 7616 | Bs.44.399,52 |
| $# FFTRU / Trichloroacetic Acid, Urine | 7264 | Bs.25.227,00 |
| $# FFTYC / Collagen Type II antibody | 7950 | Bs.32.290,56 |
| $# FGFB/ Transforming Growth Factor beta, Serum | 7707 | Bs.26.684,56 |
| $# FGLUT/ Gluten IgG | 7578 | Bs.13.454,40 |
| $# FGNRH / Gonadotropin Releasing Hormone (Gn-RH, Luteinizing Hormone-Releasing Hormone LH-RH) | 7752 | Bs.69.514,40 |
| $# FH3N5 / Hepatitis C Viral RNA Genotype 3 NS5a Drug Resistance | 7079 | Bs.193.070,64 |
| $# FH8RP / Herpesvirus 8 (HHV-8) DNA, Quantitative Real-Time PCR | 7207 | Bs.93.059,60 |
| $# FHBG / Hepatitis B Virus Genotyping | 7071 | Bs.102.814,04 |
| $# FHHV6 / Herpes Virus 6 (HHV-6) DNA, Qualitative Real-Time PCR | 7962 | Bs.72.317,40 |
| $# FHI24 / Histamine, 24-Hour Urine | 7853 | Bs.44.848,00 |
| $# FHIPP/ Toluene as Hippuric Acid, Occupational Exposure, Urine | 7263 | Bs.25.227,00 |
| $# FHLAB / HLA B High Resolution | 7544 | Bs.133.198,56 |
| $# FHSPL / Histamine Plasma | 6878 | Bs.34.757,20 |
| $# FHTL / HTLV I/II DNA, Qualitative Real-Time PCR | 7016 | Bs.73.550,72 |
| $# FHV7P - Overview: Herpesvirus 7 (HHV-7) DNA, Quantitative Real-Time PCR | 7963 | Bs.89.471,76 |
| $# FIERA / IgE Receptor Antibody | 7882 | Bs.51.350,96 |
| $# FIFLC / Immunofixation with Free Light Chains, Quantitative, Urine (Bence Jones) | 7952 | Bs.58.078,16 |
| $# FIFNY / Interferon-gamma (IFN-y) Serum | 7701 | Bs.40.923,80 |
| $# FIGF2 / Insulin-like Growth Factor 2 (IGF-2) | 8000 | Bs.28.030,00 |
| $# FIL2M / Interleukin 2 | 7505 | Bs.34.757,20 |
| $# FIL2S / Interleukin 2 Receptor, Soluble | 7985 | Bs.55.835,76 |
| $# FIL8S / Interleukin 8 (IL-8) Serum | 7683 | Bs.40.811,68 |
| $# FINA / NAbFeron (IFNB-1) Neutralizing Antibody Test | 7702 | Bs.170.758,76 |
| $# FINTA / Interleukin 1-Alpha | 7605 | Bs.69.514,40 |
| $# FINTB / Interleukin 1-Beta | 7756 | Bs.55.835,76 |
| $# FJCQP/ JC Polyoma Virus DNA, Quantitative Real-Time PCR, Plasma | 6604 | Bs.93.059,60 |
| $# FLACF / Lactoferrin, fecal by ELISA | 7657 | Bs.26.684,56 |
| $# FLCS / Immunoglobulin Free Light Chains, Serum (Kappa y Lambda) | 7393 | Bs.20.966,44 |
| $# FLT / FLT3 Mutation Analysis, Varies | 7884 | Bs.74.784,04 |
| $# FMERC / Mercaptopurine (6- MP, Purinethol ) | 7358 | Bs.31.393,60 |
| $# FMITO / Mitotane (Lysodren) | 7745 | Bs.32.066,32 |
| $# FMYO3 / MyoMarker 3 profile (Myositis/ Dermatomiositis) | 7474 | Bs.88.911,16 |
| $# FPAIG / Plasminogen Activator Inhibitor-1, 4G/5G Genotyping (PAI-1 Polymorphism) | 7377 | Bs.97.544,40 |
| $# FPEPS / Pepsinogen I | 6978 | Bs.60.544,80 |
| $# FPHEN / Benzene as Phenol, Occupational exposure, Urine | 7456 | Bs.23.881,56 |
| $# FPOLO / Poliovirus (Types 1, 3) Antibodies, Neutralization | 7904 | Bs.54.378,20 |
| $# FRISP / Risperidone (Risperdal) and 9-Hydroxyrisperidone | 8024 | Bs.22.984,60 |
| $# FRUCT/ Fructosamine, Serum | 7638 | Bs.5.045,40 |
| $# FSILS / Silicon, Serum | 6579 | Bs.30.720,88 |
| $# FSINS / Sinemet, Serum (carbidopa, levodopa) | 7398 | Bs.61.105,40 |
| $# FXS / Fragile X Syndrome, Molecular Analysis | 6836 | Bs.173.337,52 |
| $# G6PD1 / Glucose-6-Phosphate Dehydrogenase (G-6-PD), Enzyme Activity, Blood | 7215 | Bs.8.409,00 |
| $# G6PDB / Glucose-6-Phosphate Dehydrogenase (G6PD) Full Gene Sequencing, Varies | 7821 | Bs.233.882,32 |
| $# GAAW / Acid Alpha-Glucosidase, Leukocytes | 7879 | Bs.149.119,60 |
| $# GALP / Galactose, Quantitative, Plasma | 7890 | Bs.18.611,92 |
| $# GALT/ Galactose 1 Phosphate Uridyltransferase (GALT) Blood | 7630 | Bs.15.921,04 |
| $# GAST / Gastrin, serum | 6638 | Bs.5.045,40 |
| $# GBAW / Beta-Glucosidase, Leukocytes | 7478 | Bs.138.580,32 |
| $# GBAZ / Gaucher Disease, Full Gene Analysis | 7477 | Bs.289.605,96 |
| $# GCRNA/ Neisseria gonorrhoeae by Nucleic Acid Amplification (GEN-PROBE) | 7162 | Bs.10.651,40 |
| $# GD65C / Glutamic Acid Decarboxylase (GAD65) Antibody Assay, Spinal Fluid | 7755 | Bs.13.678,64 |
| $# GIAR / Giardia Antigen, Feces | 7863 | Bs.7.512,04 |
| $# GLP / Glucagon, plasma | 6652 | Bs.12.557,44 |
| $# GSH / Glutathione, Blood | 8019 | Bs.100.571,64 |
| $# H2BR / HER2 Amplification Associated with Breast Cancer, FISH, Tissue | 6845 | Bs.261.239,60 |
| $# HAPT / Haptoglobin, Serum | 7367 | Bs.4.484,80 |
| $# HBOCZ / BRCA1/BRCA2 Genes, Full Gene Analysis, Varies | 7658 | Bs.387.935,20 |
| $# HBVQN / Hepatitis B Virus (HBV) DNA Detection and Quantification by Real-Time PCR, Serum (Carga Viral) | 6597 | Bs.40.699,56 |
| $# HCQ / Hydroxychloroquine, Serum | 7832 | Bs.72.878,00 |
| $# HCVG / Hepatitis C Virus Genotype, Serum | 6623 | Bs.195.649,40 |
| $# HCVQN / Hepatitis C Virus (HCV) RNA Detection and Quantification by PCR (RT-PCR), (Carga Viral) | 6576 | Bs.22.760,36 |
| $# HE4 / Human Epididymis Protein 4, Serum | 7241 | Bs.41.148,04 |
| $# HEAG / Hepatitis B e Antigen and Hepatitis B e Antibody, Serum | 8016 | Bs.8.409,00 |
| $# HEPTP / Heparin Anti-Xa, Plasma | 7951 | Bs.19.733,12 |
| $# HG/ Mercury, Blood | 6605 | Bs.6.502,96 |
| $# HGBCE/ Hemoglobin Variant, A2 and F Quantitation, Blood | 7469 | Bs.58.863,00 |
| $# HGH / Growth Hormone, Serum | 6980 | Bs.3.924,20 |
| $# HGRCR/ Mercury/Creatinine Ratio, Random, Urine | 6816 | Bs.9.530,20 |
| $# HGU / Mercury, 24 Hour, Urine | 8048 | Bs.9.530,20 |
| $# HIAA/ 5-Hydroxyindoleacetic Acid 24 Hour Urine | 6554 | Bs.4.484,80 |
| $# HIAAP / 5-Hydroxyindoleacetic Acid, Plasma | 7740 | Bs.4.484,80 |
| $# HIPA / Hippuric Acid, Urine | 6651 | Bs.29.711,80 |
| $# HITIG / Heparin - PF4 IgG, Antibody, Serum | 7695 | Bs.17.490,72 |
| $# HIVDR / HIV-1 Genotypic Drug Resistance to Reverse Transcriptase, Protease, and Integrase Inhibitors, Plasma | 6617 | Bs.129.947,08 |
| $# HIVQN / HIV-1 RNA Detection and Quantification, Plasma | 6571 | Bs.16.033,16 |
| $# HL57R / HLA-B*57:01 Genotype, Pharmacogenomics, Varies (Abacavir) | 7822 | Bs.196.210,00 |
| $# HL58R / HLA-B*5801 Genotype, Allopurinol Hypersensitivity, Varies | 7823 | Bs.158.089,20 |
| $# HMDB / Heavy Metals Screen with Demographics, Blood | 7532 | Bs.16.818,00 |
| $# HMEP/ Hemiplegic Migraine With or Without Epilepsy Gene Panel, Varies, | 8039 | Bs.308.330,00 |
| $# HMHA / Heavy Metals, Hair | 6818 | Bs.211.682,56 |
| $# HPANP / Hereditary Pancreatitis Gene Panel, Varies (genes CFTR, PRSS1, SPINK1) | 7214 | Bs.676.868,44 |
| $# HPFH / Hemoglobin F Distribution, Blood | 7850 | Bs.17.378,60 |
| $# HSTU/ Histoplasma Antigen, Quantitative Enzyme Immunoassay, Random, Urine | 7727 | Bs.47.426,76 |
| $# HSVG / Herpes Simplex Virus (HSV) Type 1- and Type 2-Specific Antibodies, IgG Serum | 7092 | Bs.5.045,40 |
| $# HSVPB / Herpes Simplex Virus (HSV), Molecular Detection, PCR, Blood I, II | 7523 | Bs.13.230,16 |
| $# HTGR / Thyroglobulin, Tumor Marker Reflex, Serum | 7783 | Bs.163.022,48 |
| $# HTLLC / Human T-Cell Lymphotropic Virus Types 1 and 2 (HTLV-1/-2) Antibody Confirmation, Spinal Fluid | 7762 | Bs.176.813,24 |
| $# HTLVL / Human T-Cell Lymphotropic Virus Types I and II Antibody Screen with Confirmation, Serum | 7892 | Bs.30.160,28 |
| $# HVA / Homovanillic Acid (HVA), 24 Hour, Urine | 6814 | Bs.8.184,76 |
| $# HVAR / Homovanillic Acid (HVA), Random, Urine | 6850 | Bs.8.184,76 |
| $# HYOX / Hyperoxaluria Panel, Urine | 7040 | Bs.29.151,20 |
| $# IA2 / Islet Antigen 2 (IA-2) Antibody, Serum (Tyrosine Phosphatase) | 7190 | Bs.18.724,04 |
| $# IABCS / B-Cell Phenotyping Profile for Immunodeficiency and Immune Competence Assessment, Blood | 7156 | Bs.85.771,80 |
| $# IBDP / Inflammatory Bowel Disease Serology Panel, Serum | 7301 | Bs.35.429,92 |
| $# IFG23 / Intact Fibroblast Growth Factor 23, Serum | 7503 | Bs.134.319,76 |
| $# IGFB3 / Insulin-Like Growth Factor Binding Protein 3 (IGFBP-3), Serum | 6699 | Bs.5.942,36 |
| $# IGFMS/ Insulin-Like Growth Factor 1, LC-MS, SERUM (Somatomedina C) (IGF1) | 6613 | Bs.16.818,00 |
| $# IGGS / IgG Subclasses, Serum | 7502 | Bs.11.548,36 |
| $# IGGS4 / Immunoglobulin Subclass IgG4, Serum | 6565 | Bs.49.332,80 |
| $# IHC / Mismatch Repair (MMR) Protein Immunohistochemistry Only, Tumor | 7724 | Bs.178.046,56 |
| $# IL28Q / Interleukin 28B (IL28B) Variant (rs12979860), Varies | 7824 | Bs.170.983,00 |
| $# IL6DX / Interleukin-6, Serum | 7504 | Bs.50.005,52 |
| $# INHA/ Inhibin A, Tumor Marker, Serum | 7670 | Bs.8.633,24 |
| $# INHB / Inhibin B, Serum | 7543 | Bs.16.481,64 |
| $# IOD / Iodine, Serum | 7560 | Bs.17.266,48 |
| $# JAK2B/ JAK2 V617F Mutation Detection, Blood | 6559 | Bs.103.150,40 |
| $# JAK2M / JAK2 V617F Mutation Detection, Bone Marrow | 8046 | Bs.103.150,40 |
| $# K11CS / Kelch-Like Protein 11 Antibody, Cell Binding Assay, Serum | 8014 | Bs.123.892,60 |
| $# KIDST / Kidney Stone Analysis | 7771 | Bs.5.269,64 |
| $# KRASD / Cell-free DNA KRAS 12, 13, 61,146 Blood | 7465 | Bs.239.264,08 |
| $# L3AFP / Alpha-Fetoprotein (AFP) L3% and Total, Hepatocellular Carcinoma Tumor Marker, Serum | 7548 | Bs.31.393,60 |
| $# LAGGT / Granulocyte Antibodies, Serum ( Anti-Neutrophil) | 7191 | Bs.33.636,00 |
| $# LCADP / Adenovirus, Molecular Detection, PCR, Plasma | 7345 | Bs.11.436,24 |
| $# LD / Lactate Dehydrogenase (LD), Serum | 7522 | Bs.7.848,40 |
| $# LEFLU/ Leflunomide Metabolite (Teriflunomide), Serum | 7268 | Bs.80.950,64 |
| $# LEIS / Leishmaniasis (Visceral) Antibody, Serum | 7569 | Bs.11.772,60 |
| $# LEPD / Lepidoglyphus destructor, IgE, Serum | 7966 | Bs.5.381,76 |
| $# LEPDT /Leptospira, IgM, Serum | 7411 | Bs.40.923,80 |
| $# LEVE/ Levetiracetam, (Keppra®) Serum | 6557 | Bs.6.727,20 |
| $# LIPA1 / Lipoprotein (a), Serum | 7545 | Bs.4.484,80 |
| $# LITH / Lithium, Serum | 7031 | Bs.5.045,40 |
| $# LNBAB / Lyme Central Nervous System Infection IgG with Antibody Index Reflex, Serum and Spinal Fluid | 7795 | Bs.156.968,00 |
| $# LNBAI / Lyme Central Nervous System Infection IgG, Antibody Index, Spinal Fluid | 7976 | Bs.149.680,20 |
| $# LNGPR / Lung Cancer-Targeted Gene Panel with Rearrangement, Tumor | 7562 | Bs.627.311,40 |
| $# LQTGP / Long QT Syndrome Multi-Gene Panel, Blood | 7438 | Bs.426.056,00 |
| $# LVZV Varicella-Zoster Virus, Molecular Detection, PCR LCR | 7261 | Bs.21.078,56 |
| $# LYME/ Lyme Disease Serology, Serum ( Borrelia burgdorferi) | 6621 | Bs.14.575,60 |
| $# LYMPV / Lyme Disease, Molecular Detection, PCR, Varies | 7115 | Bs.24.666,40 |
| $# MCRPL / Macroprolactin, Serum | 7093 | Bs.17.154,36 |
| $# METAF/ Metanephrines, Fractionated, 24 hour, Urine | 6695 | Bs.6.166,60 |
| $# METF / MET (7q31), FISH, Tissue | 7667 | Bs.345.665,96 |
| $# MFBNG / FBN1 Full Gene Sequencing with Deletion/Duplication, Varies (Marfan) | 7877 | Bs.417.198,52 |
| $# MGS / Magnesiun, serum | 7396 | Bs.7.848,40 |
| $# MHPRP - Mycoplasma hominis, Molecular Detection, PCR, Plasma | 7660 | Bs.30.945,12 |
| $# MITOP / Mitochondrial Full Genome Analysis by Next Generation Sequencing (NGS) | 7181 | Bs.461.598,04 |
| $# MMAS / Methylmalonic Acid (MMA), Quantitative, Serum | 7219 | Bs.8.409,00 |
| $# MMAU / Methylmalonic Acid, Quantitative, Urine | 8061 | Bs.15.696,80 |
| $# MMPGM / Mumps Virus Antibody, IgM and IgG, Serum (parotiditis) | 7728 | Bs.7.848,40 |
| $# MMRV/ MMRV Immune Status Profile, Serum | 7510 | Bs.17.714,96 |
| $# MNS / Manganese, Serum | 7161 | Bs.8.633,24 |
| $# MOGFS / Myelin Oligodendrocyte Glycoprotein (MOG-IgG1) Fluorescence-Activated Cell Sorting (FACS) Assay, Serum | 7412 | Bs.72.317,40 |
| $# MPA / Mycophenolic Acid, Serum | 7076 | Bs.7.848,40 |
| $# MPQU /Monoclonal Protein Quantitation, 24 Hour, Urine (Electrophoresis) | 7287 | Bs.58.302,40 |
| $# MPSER / Mucopolysaccharides Quantiteve, Serum | 7046 | Bs.138.692,44 |
| $# MPSQU / Mucopolysaccharides Quantitative Randon, Urine | 6835 | Bs.197.891,80 |
| $# MPU / Monoclonal Protein Studies, 24 Hour, Urine (Inmunofijación) | 7622 | Bs.15.248,32 |
| $# MTHX / Methotrexate, Seruma | 7880 | Bs.14.799,84 |
| $# MURA / Lysozyme (Muramidase), Plasma | 7936 | Bs.12.333,20 |
| $# MYCO/ Mycoplasma pneumoniae Antibodies, IgG and IgM, Serum | 7008 | Bs.73.774,96 |
| $# MYD88 / MYD88 - MYD88, L265P, Somatic Gene Mutation, DNA Allele-Specific PCR, Varies | 7714 | Bs.208.543,20 |
| $# MYGLS / Myoglobin, Serum | 7703 | Bs.7.287,80 |
| $# MYGLU / Myoglobin, Random, Urine | 7766 | Bs.5.606,00 |
| $# NAT2 / N-Acetyltransferase 2 Gene (NAT2), Full Gene Sequence, Whole Blood | 7825 | Bs.152.258,96 |
| $# NEFA / Free Fatty Acids, Total, Serum | 7034 | Bs.12.108,96 |
| $# NGAML / MayoComplete Acute Myeloid Leukemia, 11-Gene Panel, Varies | 7942 | Bs.349.365,92 |
| $# NGSHM /OncoHeme Next-Generation Sequencing for Myeloid Neoplasms, Varies | 7580 | Bs.263.257,76 |
| $# NH3V / Ammonia, Plasma | 7607 | Bs.53.257,00 |
| $# NICOS / Nicotine and Metabolites, Serum | 7527 | Bs.14.351,36 |
| $# NICOU / Nicotine and Metabolites, Urine | 7168 | Bs.6.727,20 |
| $# NIS / Nickel, Serum | 7250 | Bs.13.790,76 |
| $# NMH24 / N-Methylhistamine, 24 Hour, Urine | 7083 | Bs.14.799,84 |
| $# NMOFC / Neuromyelitis Optica (NMO)/Aquaporin-4-IgG Fluorescence-Activated Cell Sorting (FACS) Assay, Spinal Fluid | 6712 | Bs.46.193,44 |
| $# NMOFS/ Neuromyelitis Optica (NMO)/Aquaporin-4-IgG Fluorescence-Activated Cell Sorting (FACS) Assay, Serum | 6578 | Bs.46.193,44 |
| $# NONCP / Neuro-Oncology Expanded Gene Panel with Rearrangement, Tumor | 8002 | Bs.895.278,20 |
| $# NPM1Q - Nucleophosmin (NPM1) Mutation Analysis, Varies | 7758 | Bs.70.971,96 |
| $# NSE / Neuron-Specific Enolase (NSE), Serum | 7128 | Bs.8.969,60 |
| $# NTRK / NTRK Gene Fusion Panel, Tumor | 7666 | Bs.346.114,44 |
| $# OAU/ Organic Acids Screen, Urine | 6662 | Bs.8.969,60 |
| $# OHPG / 17-Hydroxyprogesterone, Serum | 7437 | Bs.6.166,60 |
| $# OMHC / Oxcarbazepine Metabolite (MHC), Serum (Trileptal) | 6595 | Bs.6.166,60 |
| $# OSCAL / Osteocalcin, Serum | 7442 | Bs.9.530,20 |
| $# OXYSU - Oxycodone Screen, Random, Urine | 7570 | Bs.145.756,00 |
| $# PACP / Prostatic Acid Phosphatase, Serum | 7805 | Bs.5.830,24 |
| $# PAI1 / Plasminogen Activator Inhibitor Antigen, Plasma | 7610 | Bs.42.941,96 |
| $# PALB / Prealbumin (PAB), Serum | 7454 | Bs.4.484,80 |
| $# PARVS / Parvovirus B19 Antibodies, IgG and IgM, Serum | 7546 | Bs.5.942,36 |
| $# PBDV / Lead venous with Demographics, Blood (Plomo) | 6606 | Bs.3.363,60 |
| $# PBNP1 / NT- Pro B -Type Natiruretic Peptide (BNP), Serum | 6691 | Bs.19.284,64 |
| $# PBORB / Lyme Disease (Borrelia burgdorferi), Blood Molecular Detection, PCR | 6837 | Bs.24.666,40 |
| $# PBU / Lead, 24 Hour, Urine (plomo) | 8047 | Bs.8.409,00 |
| $# PCGP / Porphyria Comprehensive Gene Panel, Varies | 8003 | Bs.413.162,20 |
| $# PEE / Porphyrins Evaluation, Whole Blood | 7998 | Bs.33.075,40 |
| $# PGN/ / Pregabalin, Serum (Lyrica) | 7785 | Bs.29.375,44 |
| $# PGXQP / Focused Pharmacogenomics Panel, Varies | 7820 | Bs.1.386.139,56 |
| $# PINP / Procollagen I Intact N-Terminal, Serum | 7893 | Bs.101.020,12 |
| $# PINS / Proinsulin, Plasma | 7455 | Bs.12.893,80 |
| $# PK1 / Pyruvate Kinase Enzyme Activity, Blood | 6715 | Bs.17.939,20 |
| $# PKU / Phenylalanine and Tyrosine, Plasma | 8054 | Bs.19.733,12 |
| $# PLASF / Plasma Cell Proliferative Disorder, FISH, Tissue | 7711 | Bs.500.503,68 |
| $# PLHBB / Plasma Free Hemoglobin, Plasma | 7773 | Bs.10.651,40 |
| $# PLPMA / Prolactin, Pituitary Macroadenoma, Serum (dilution) | 7579 | Bs.18.163,44 |
| $# PMET / Metanephrines, Fractionated, Free, Plasma | 6656 | Bs.8.745,36 |
| $# PMPDD / PMP22 Gene, Large Deletion/Duplication Analysis, Varies (Charcot Marie Toth type A) | 7742 | Bs.184.998,00 |
| $# PN23M / Streptococcus pneumoniae IgG Antibodies, 23 Serotypes, Serum | 7807 | Bs.17.939,20 |
| $# PNTFT / Phenytoin, Total and Free, Serum (Dilantin/ Epamin) | 7255 | Bs.7.287,80 |
| $# POX / Fatty Acid Profile, Peroxisomal (C22-C26), Serum (ácidos grasos de cadena muy larga VLCFA) | 7862 | Bs.21.302,80 |
| $# PPFWE / Protoporphyrins, Fractionation, Washed Erythrocytes | 7537 | Bs.107.971,56 |
| $# PR3 / Proteinase 3 Antibodies, IgG, Serum | 7597 | Bs.10.090,80 |
| $# PRA/ Renin Activity, Plasma | 6698 | Bs.4.148,44 |
| $# PREGN / Pregnenolone, Serum | 7989 | Bs.54.602,44 |
| $# PSAFT / Prostate-Specific Antigen (PSA), Total and Free, Serum | 7224 | Bs.7.287,80 |
| $# PSAU / Prostate-Specific Antigen (PSA) Ultrasensitive, Serum | 7319 | Bs.5.830,24 |
| $# PSGN / Plasminogen Activity, Plasma | 7005 | Bs.23.096,72 |
| $# PSYQP / Psychotropic Pharmacogenomics Gene Panel, Varies | 7826 | Bs.1.583.470,76 |
| $# PVJAK /Polycythemia Vera, JAK2 V617F with Reflex to JAK2 Exon 12-15, Sequencing for Erythrocytosis, Varies | 7715 | Bs.203.834,16 |
| $# PWAS / Prader-Willi/Angelman Syndrome, Molecular Analysis, Varies | 7696 | Bs.86.332,40 |
| $# PYR/ Pyruvic Acid, Blood | 8004 | Bs.57.853,92 |
| $# QFEVR / Q Fever Antibody Screen with Titer Reflex, Serum | 7993 | Bs.35.878,40 |
| $# QFT4 / QuantiFERON-TB Gold Plus, Blood (IGRA) | 6569 | Bs.16.257,40 |
| $# QMPSS / Monoclonal Protein Study, Quantitative, Serum | 7284 | Bs.130.059,20 |
| $# RETF / Lung Cancer, RET (10q11) Rearrangement, FISH, Tissue | 7668 | Bs.359.680,96 |
| $# RETZZ / Multiple Endocrine Neoplasia Type 2 Syndrome, RET, Full Gene Analysis, Varies | 7400 | Bs.317.972,32 |
| $# RIB / Ribosome P Antibodies, IgG, Serum | 6870 | Bs.12.333,20 |
| $# RNAP / RNA Polymerase III Antibodies, IgG, Serum | 7017 | Bs.12.333,20 |
| $# ROS1F / Lung Cancer, ROS1 (6q22) Rearrangement, FISH, Tissue | 7521 | Bs.366.408,16 |
| $# RT3 / T3 (Triiodonthyronine ), Reverse, Serum | 7566 | Bs.109.204,88 |
| $# RTSC / Reptilase Time, Plasma | 7991 | Bs.14.575,60 |
| $# SALCT / Cortisol, Saliva | 7647 | Bs.14.351,36 |
| $# SCA / FCNAB Chromatin (Nucleosomal) Antibody | 7364 | Bs.26.684,56 |
| $# SCAP / Spinocerebellar Ataxia Repeat Expansion Panel, Varies | 7891 | Bs.154.165,00 |
| $# SCCA /Squamous Cell Carcinoma Antigen, Serum (antígeno de células escamosas) | 7415 | Bs.64.693,24 |
| $# SCCNP / Severe Congenital and Cyclic Neutropenia Gene Panel, Varies (30genes), NGS | 7978 | Bs.434.352,88 |
| $# SCE / VWACT / Von Willebrand Factor Activity, Plasma CON (RISTOCETIN) | 7376 | Bs.143.289,36 |
| $# SCE / 25HDN / 25-Hydroxyvitamin D2 and D3, Serum | 6591 | Bs.6.166,60 |
| $# SCE / ATTF / Antithrombin III Activity, P | 6616 | Bs.8.969,60 |
| $# SCE / B2M / Beta-2-Microglobulin (Beta-2-M), Serum | 7163 | Bs.3.363,60 |
| $# SCE / CFX / Protein C activity, plasma | 6663 | Bs.8.521,12 |
| $# SCE / COM/ Complement, Total, Serum ( CH50) | 7103 | Bs.3.924,20 |
| $# SCE / CPR / C-Peptide, Serum | 7373 | Bs.4.484,80 |
| $# SCE / DAGL/ Gliadin (Deamidated) Antibody, IgA Serum | 7395 | Bs.7.848,40 |
| $# SCE / DGGL/ Gliadin (Deamidated) Antibody, IgG Serum | 7394 | Bs.7.848,40 |
| $# SCE / EPO /Erythropoietin (EPO), Serum | 7027 | Bs.4.148,44 |
| $# SCE / F_11 / Coagulation Factor XI Activity Assay, Plasma | 7385 | Bs.12.893,80 |
| $# SCE / F_12 / Coagulation Factor XII Activity Assay, Plasma | 7386 | Bs.21.078,56 |
| $# SCE / F_9 / Coagulation Factor IX Activity Assay, Plasma | 6599 | Bs.7.624,16 |
| $# SCE / F8A / Coagulation Factor VIII Activity Assay, Plasma | 6869 | Bs.8.409,00 |
| $# SCE / FGAGM / Ganglioside (GM1, GM2, GD1b, and GQ1b) Antibodies, | 6773 | Bs.52.696,40 |
| $# SCE / HCYSS Homocysteine, Total, Serum | 7266 | Bs.6.727,20 |
| $# SCE / IFBA/ Intrinsic Factor Blocking Antibody, Serum | 6798 | Bs.6.166,60 |
| $# SCE / LACS1 / Lactate, Plasma (Acido láctico) | 7381 | Bs.4.821,16 |
| $# SCE / PCAG Protein C Antigen, Plasma | 6575 | Bs.8.633,24 |
| $# SCE / PLABN/ Platelet Antibody Screen, Serum (Anti - plaquetarios) | 7155 | Bs.12.893,80 |
| $# SCE / PSTF Protein S Antigen, Plasma | 7361 | Bs.6.727,20 |
| $# SCE / PTH2 / Parathyroid Hormone (PTH), Serum | 7483 | Bs.8.969,60 |
| $# SCE / SFX / Protein S activity, plasma | 6645 | Bs.12.557,44 |
| $# SCE / THYRO/ Thyrotropin Receptor Antibody, Serum ( Receptor TSH ) | 6639 | Bs.6.727,20 |
| $# SCE / TTST/ Testosterone, total, serum | 7432 | Bs.5.606,00 |
| $# SCE/ PRL / Prolactin, Serum | 7405 | Bs.5.045,40 |
| $# SCE/ AMH1 / Antimullerian Hormone, Serum | 6710 | Bs.64.917,48 |
| $# SCE/ FCQBA / C1Q Binding Assay (Complejo Inmune Circulante - CIC) | 6630 | Bs.14.575,60 |
| $# SCE/ MUSK/ Muscle-Specific Kinase (MuSK) Autoantibody, Serum | 7375 | Bs.191.613,08 |
| $# Scl 70 Antibodies, IgG, Serum | 8058 | Bs.5.045,40 |
| $# SER / Serotonin, Serum | 6552 | Bs.8.409,00 |
| $# SERU / Serotonin, 24 hour, urine | 7480 | Bs.13.118,04 |
| $# SES / Selenium, serum | 6963 | Bs.7.848,40 |
| $# SFGP - Spotted Fever Group Antibody, IgG and IgM, Serum | 7750 | Bs.12.445,32 |
| $# SHSTO / Histoplasma Antibody, Serum | 7547 | Bs.79.605,20 |
| $# SIIRO / Sirolimus, Blood | 7553 | Bs.5.606,00 |
| $# SLC1Q / Solute Carrier Organic Anion Transporter Family Member 1B1 (SLCO1B1) Genotype, Statin, Varies | 7827 | Bs.188.025,24 |
| $# SLEG/ Legionella pneumophila (Legionnaires Disease), Antibody, Serum | 7470 | Bs.6.278,72 |
| $# SLL / Small Lymphocytic Lymphoma, FISH, Tissue | 7694 | Bs.343.872,04 |
| $# SPAS / Arsenic Speciation, Random, Urine | 7511 | Bs.19.284,64 |
| $# STER / Sterols, P | 8060 | Bs.49.669,16 |
| $# STRNG / Strongyloides Antibody, IgG, Serum | 7741 | Bs.26.684,56 |
| $# SULFU / Sulfate, 24 Hour, Urine | 7964 | Bs.13.678,64 |
| $# T790M / Cell-Free DNA EGFR T790M Mutation | 7463 | Bs.152.258,96 |
| $# TAKRO/ Tacrolimus, Blood | 6990 | Bs.6.727,20 |
| $# TCGRV / T-Cell Receptor Gene Rearrangement, PCR, Varies | 7552 | Bs.242.179,20 |
| $# TDP / Thiamin (Vitamin B1), Whole Blood | 6961 | Bs.11.772,60 |
| $# TELDP /Telomere Biology Disorders Gene Panel, Varies | 7700 | Bs.434.465,00 |
| $# THCU /Carboxy-Tetrahydrocannabinol (THC) Confirmation, Urine | 7507 | Bs.11.436,24 |
| $# THSD7 / Thrombospondin Type-1 Domain-Containing 7A Antibodies, Serum | 7744 | Bs.112.456,36 |
| $# TLCU / Immunoglobulin Total Light Chains, Urine (Kappa y Lambda) | 7639 | Bs.17.042,24 |
| $# TOPI / Topiramate, Serum | 6558 | Bs.8.409,00 |
| $# TPMT3 / Thiopurine Methyltransferase Activity Profile, Erythrocytes | 7887 | Bs.44.848,00 |
| $# TPNI / Troponin I, Serum | 7111 | Bs.77.026,44 |
| $# TPNUQ / Thiopurine Methyltransferase (TPMT) and Nudix Hydrolase (NUDT15) Genotyping, Varies | 7828 | Bs.112.120,00 |
| $# TRSF / Transferrin, Serum | 7555 | Bs.32.514,80 |
| $# TRYPI / Tyrophagus putrescentiae, IgE, Serum | 7967 | Bs.5.381,76 |
| $# TRYPP / Tryptophan, Plasma | 6885 | Bs.34.196,60 |
| $# TSCP / Overview: Tuberous Sclerosis Gene Panel, Varies | 7902 | Bs.308.442,12 |
| $# TSI / Thyroid-Stimulating Immunoglobulin (TSI), Serum | 7172 | Bs.22.648,24 |
| $# TTGA / Tissue Transglutaminase (tTG) Antibody, IgA, Serum | 6634 | Bs.5.606,00 |
| $# TTGG / Tissue Transglutaminase (tTG) Antibody, IgG, Serum | 6635 | Bs.5.606,00 |
| $# TTRZ /TTR Gene, Full Gene Analysis, Vries (Amyloidosis) | 6858 | Bs.386.029,16 |
| $# TWRP/ Tropheryma whipplei, Molecular Detection, PCR, Varies | 7524 | Bs.33.860,24 |
| $# U1A1Q / UDP-Glucuronosyltransferase 1A1 TA Repeat Genotype, UGT1A1, Varies | 7829 | Bs.180.961,68 |
| $# UE3 / Estriol, Unconjugated, Serum | 7573 | Bs.5.381,76 |
| $# UGTFG/ UDP-Glucuronosyl Transferase 1A1 (UGT1A1), Full Gene Sequencing | 7212 | Bs.213.812,84 |
| $# UHSD1/ Hemosiderin, Random, Urine | 7692 | Bs.5.942,36 |
| $# VALPA / Valproic Acid, total serum | 7397 | Bs.5.606,00 |
| $# VDSF / VDRL, Spinal Fluid | 7763 | Bs.8.969,60 |
| $# VEGF / Vascular Endothelial Growth Factor plasma | 6588 | Bs.69.514,40 |
| $# VIP / Vasoactive Intestinal Polypeptide, Plasma | 7598 | Bs.14.911,96 |
| $# VITA / Vitamin A, Serum | 6673 | Bs.5.942,36 |
| $# VITB3 / Vitamin B3 and Metabolites, Plasma | 7619 | Bs.48.547,96 |
| $# VITC/ Ascorbic Acid (Vitamin C), Plasma | 7561 | Bs.8.969,60 |
| $# VITE / Vitamin E, Serum | 6674 | Bs.5.830,24 |
| $# VITK1 / Vitamin K1, Serum | 6675 | Bs.46.866,16 |
| $# VMA/ Vanillylmandelic Acid (VMA), 24 hour, Urine | 6696 | Bs.5.830,24 |
| $# VMAR / Vanillylmandelic Acid (VMA), Random, Urine | 6851 | Bs.5.830,24 |
| $# VORI / Voriconazole, Serum | 7851 | Bs.17.154,36 |
| $# VWAG/ Von Willebrand Factor Antigen, Plasma | 6600 | Bs.7.848,40 |
| $# VWD8B Von Willebrand Disease 2N (Subtype Normandy), Plasma | 7146 | Bs.195.313,04 |
| $# VWFMS/ Von Willebrand Factor Multimer Analysis, Plasma | 7145 | Bs.15.808,92 |
| $# VZGM / Varicella-Zoster Antibody, IgM and IgG (Separate Determinations), Serum | 6964 | Bs.8.409,00 |
| $# VZIKM / Zika Virus IgM Antibody Capture ELISA, Serum | 7290 | Bs.62.787,20 |
| $# VZIKS / Zika Virus PCR moleciular Detection, Serum | 7204 | Bs.87.789,96 |
| $# WARSQ / Warfarin Response Genotype, Varies | 7830 | Bs.141.271,20 |
| $# WESMT / Whole Exome and Mitochondrial Genome Sequencing, Varies | 8040 | Bs.1.260.453,04 |
| $# WHIPB / Tropheryma whipplei, Molecular Detection, PCR, Blood | 7217 | Bs.33.860,24 |
| $# WNC / West Nile Virus Antibody, IgM, Spinal Fluid | 7796 | Bs.16.930,12 |
| $# WNDZ / Wilson Disease, ATP7B Full Gene Sequencing with Deletion/Duplication, Varies (Gen ATP7B) | 7906 | Bs.503.979,40 |
| $# WNS / West Nile Virus Antibody, IgG and IgM, Serum | 7444 | Bs.10.427,16 |
| $# YMCRO / Y Chromosome Microdeletions, Molecular Detection | 7052 | Bs.76.802,20 |
| $# ZN_S / Zinc, Serum | 6642 | Bs.3.924,20 |
| $# ZNCRU/ Zinc/Creat Ratio, Random, U | 7160 | Bs.10.651,40 |
| $# ZONI / Zonisamide, Serum ( Zonegran) | 6680 | Bs.13.790,76 |
| Descuento Transferencias Internacionales MML | 7594 | Bs.2.915,12 |
| Descuento Transferencias Internacionales QUEST | 7595 | Bs.2.915,12 |
